Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human T cell lymphotropic virus type 1 (HTLV-1) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV-1) infected patients submitted to antiretroviral therapy (ARV) ; volume:11 ; number:1 ; day:7 ; month:1 ; year:2014 ; pages:1 ; date:1.2014
Retrovirology ; 11, Heft 1 (7.1.2014), 1, 1.2014
- Urheber
-
Rego, Filipe FA
- Beteiligte Personen und Organisationen
-
Alcantara, Luiz CJ
de Oliveira, Tulio
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-11-S1-P62
- URN
-
urn:nbn:de:1111-2016080735026
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rego, Filipe FA
- Alcantara, Luiz CJ
- de Oliveira, Tulio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2
Replication of human immunodeficiency virus type 1 in human t-cells expressing antisense RNA
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2
Replication of human immunodeficiency virus type 1 in human t-cells expressing antisense RNA
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
Inhibitors of human immunodeficiency virus type I
Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1
Replikation von "Human Immunodeficiency Virus Type 1" in primären humanen Blutmonocyten
APOBEC3G targets human T-cell leukemia virus type 1
Entry of human immunodeficiency virus type 1 in T-cells
How human T-cell leukemia virus type 1 induces diseases
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Herpes Simplex Virus Type 1 Human Cervical Dorsal Root Ganglionitis
Human immunodeficiency virus type-1 episomal cDNA in semen
Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2